COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Innovations, Inc. Announces Closing of Private Placement and Debt Refinancing Transactions

06/02/2018 - 14:30

DAVIS, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (“MBI”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental [...]

Avenue Therapeutics to Participate in Panel on Opioid Abuse at BIO CEO & Investor Conference

06/02/2018 - 14:30

NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced that Lucy Lu, M. [...]

MRI Interventions, Inc. Announces Record 629 ClearPoint® Cases in 2017

06/02/2018 - 14:09

IRVINE, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on precision MRI-Guided Neurosurgical procedures, today announced revenues for [...]

T2 Biosystems to Present at the 7th Annual Leerink Partners Global Healthcare Conference

06/02/2018 - 14:00

LEXINGTON, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ) a leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that [...]

scPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare Conference

06/02/2018 - 14:00

BURLINGTON, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused [...]

Corium to Present at Upcoming Healthcare Investor Conferences

06/02/2018 - 14:00

MENLO PARK, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Mapi Pharma to Host Key Opinion Leader Meeting on Long Acting Glatiramer Acetate (GA Depot) for Multiple Sclerosis

06/02/2018 - 14:00

NESS ZIONA, Israel, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical late stage biopharmaceutical company, announced today that it will host a Key Opinion Leader (KOL) luncheon on its GA [...]

Mr. David Ben Naim, CPA, MBA Joins Todos Medical as Chief Financial Officer

06/02/2018 - 14:00

REHOVOT, Israel, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Todos Medical, Ltd. Inc. (OTCQB:TOMDF) ( www.todosmedical.com ), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early [...]

Daré Bioscience, Inc. to Present at the 2018 BIO CEO & Investor Conference

06/02/2018 - 14:00

SAN DIEGO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a healthcare company committed to the development and commercialization of innovative products in women’s reproductive health, today [...]

Fibrocell to Present at 20th Annual BIO CEO & Investor Conference

06/02/2018 - 14:00

EXTON, Pa., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]

CymaBay Therapeutics to Participate in Investor Conferences in February

06/02/2018 - 14:00

NEWARK, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

David Kendall Joins MannKind as Chief Medical Officer

06/02/2018 - 14:00

WESTLAKE VILLAGE, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD ) today announced that David M. Kendall, MD, will join the company as Chief Medical Officer and assume full responsibility [...]

Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations

06/02/2018 - 14:00

TORONTO, ON, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals, Inc. (OTC: EAPH), announces it has initiated discussions to transfer part of its licensed woman’s diagnostic and treatment products to another [...]

Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome

06/02/2018 - 14:00

EMERYVILLE, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]

Immunomedics to Report Second Quarter Fiscal 2018 Results and Host Conference Call and Webcast on February 8, 2018

06/02/2018 - 14:00

MORRIS PLAINS, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that it will host a conference call on Thursday, February 8, 2018 at 5:00 p.m. [...]

Actinium Pharmaceuticals Announces Trial to Study Actimab-A in Combination with CLAG-M for Relapsed or Refractory AML Patients

06/02/2018 - 13:30

- Actimab-A plus CLAG-M further expands Actinium’s CD33 program and addressable patient population of Actimab-A - Combination aligns with Actinium’s focus on improving bone marrow transplant access and outcomes through [...]

Otonomy Announces Multiple Presentations for Hearing Loss and Tinnitus Programs at Upcoming Association for Research in Otolaryngology Meeting

06/02/2018 - 13:30

SAN DIEGO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced seven data presentations [...]

BioDelivery Sciences Announces BELBUCA® Patent Litigation Settlement Agreement with Teva

06/02/2018 - 13:00

RALEIGH, N.C., Feb. 06, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) today announced that it has entered into a Settlement Agreement with Teva Pharmaceuticals USA, Inc. and Teva [...]

Leap Therapeutics to Present at the 20th Annual BIO CEO & Investor Conference

06/02/2018 - 13:00

CAMBRIDGE, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, Chief [...]